|
|
|
|
Referencias Bibliográficas Aronson, M.K. et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990; 40:1102-1106. Awad, I.A., Johnson, P.C., Spetzler, R.F., Hodak, J.A. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986; 17:1090-1097. Banks, W.A., Broadwell, R.D. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutination and albumin: Pharmacokinetic and morphological assessment. J. Neurochem., 1994; 62:2404-2419. Banks, W.A., Kastin, A.J., Maness, L.M., Banks, M.F., Shayo, M., McLay, R.N. Interactions of b-amyloid with blood-brain barrier. Ann. New York Acad. Sci., 1997; 826:190-199. Bell, M.A., Ball, M.J. Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol., 1981; 53:299-318. Benson, D.F., Kuhl, D., Hawkins, R., Phelps, M., Cummings, F., Tsai, Y. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol., 1983; 40:711-714. Beyer, K., Lao, J.I., Alvarez, X.A., Cacabelos, R. Different implications of APOE-e4 in Alzheimer's disease and vascular dementia in the Spanish population. Alzheimer's Res., 1996; 2:215-220. Beyer, K., Lao, J.I., Fernández-Novoa, L., Alvarez, X.A., Sellers, M.A., Cacabelos, R. APOE e4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish population. Ann. New York Acad. Sci., 1997; 826:452-455. Bigl, M., Escherich, K. Interaction of rat brain phosphofructokinase with Alzheimer's beta A4-amyloid. Neurochem. Internt. 1995; 26:69-75. Borrnebroek, M. et al. White matter lesions and cognitive deterioration in presymptomatic carriers of amyloid precursor protein gene codon 693 mutation. Arch. Neurol., 1996; 53:43-48. Breteler, M.M. et al. Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study. Br. Med. J., 1994; 308:1604-1608. Brown, W.R., Moody, D.M., Tytell, M., Ghazi-Birry, H.S., Challa, V.R. Microembolic brain injuries from cardiac surgery: Are they seeds of future Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:386-389. Brown, W.R. et al. Histological studies of brain microemboli in humans and dogs after cardiopulmonary bypass. Echocardiography 1996; 13:559-565. Buée, L., Hof, P.R., Delacourte, A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann. New York Acad. Sci., 1997; 826:7-24. Caamaño, J., Gómez, M.J., Cacabelos, R. Transcranial Doppler ultrasonography in senile dementia: Neuropsychological correlations. Meth. Find. Exp. Clin. Pharmacol., 1993; 15:193-199. Caamaño, J., Gómez, M.J., Vinagre, D., Franco-Maside, A., Cacabelos, R. Transcranial Doppler ultrasonography in senile dementia. Drugs Today 1994; 30:283-293. Caamaño et al. Transcranial Doppler ultrasonography in neurogeriatric disorders. Neurogerontol. Neurogeriat., 1995; 1:141-158. Cacabelos, R. Enfermedad de Alzheimer. Rev. Med. Práctica Mécica, 1997; 2:124-142. Cacabelos, R. et al. Brain mapping and transcranial Doppler ultrasonography in Alzheimer's disease drug monitoring. En: Alzheimer Disease: From Molecular to Therapy. Becker, R., Giacobini, E., Eds. Birkhäuser, Boston, 1996;469-473. Crawford, F. et al. The vasoactivity of Ab peptides. Ann. New York Acad. Sci., 1997; 826:35-46. De Jong, G.I., De Vos, R.A.I., Jansen Steur, E.N.H., Luiten, P.G.M. Cerebrovascular hipoperfusion: A risk factor for Alzheimer's disease?. Ann. New York Acad. Sci., 1997; 826:56-74. De la Torre, J. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Behav. Res., 1994; 18:397-401. De la Torre, J. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:75-91. De la Torre, J., Mussivand, T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res., 1993; 15:146-153. Duara, R., Grady, C., Haxby, J. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887. Ducross, A. et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity and mapping of the locus within a 2-cM interval. Am. J. Genet., 1996; 58:171-181. Duvernoy, H.M., Delon, S., Vannson, J.L. Cortical blood vessels of the human brain. Brain Res. Bull., 1981; 7:519-579. Erecinska, M., Silver, I. ATP and brain function. J. Cereb. Blood Flow Metab., 1989; 9:2-19. Frackowiak, R.S., Pozzilli, C., Marshall, J., Lenzi, G., Jones, T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981; 104:753-778. Friedland, R.P., Budinger, T., Koss, E., Ober, B. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett., 1985; 53:235-240. Friedland, R.P. et al. Neuroimaging of vessel amyloid in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:242-247. Fung, Y.C. Biodynamics circulation. Springer-Verlag, New York, 1984. Gaehtgens, P., Marx, P. Hemorheological aspects of the pathophysiology of cerebral ischemia. J. Cereb. Blood Flow Metab., 1987; 7:259-265. Gibbs, J.M. et al. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet 1984; i:182-186. Grammas, P., Botchlet, T.R., Moore, P., Weigel, P.H. Production of neurotoxic factors by brain endothelium in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:47-55. Hachinski, V., Muñoz, D. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon. Ann. New York Acad. Sci., 1997; 826:1-6. Hachinski, V.C., Potter, P., Merskey, H. Leuko-araiosis. Arch. Neurol., 1987; 44:21-23. Han, S.H. et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol., 1994; 128:13-26. Haxby, J.V., Grady, C., Koss, E., Horwitz, B., Schapiro, M., Friedland, R.P., Rapoport, S.I. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 1988; 38:1853-1863. Hoyer, S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann. New York Acad. Sci., 1991; 640:53-58. Hoyer, S. Age as risk factor for sporadic dementia of the Alzheimer type? Ann. New York Acad. Sci., 1994; 719:248-256. Hoyer, S. Oxidative metabolism deficiencies in brains of patients with Alzheimer's diseas. Acta Neurol. Scand. , 1996; Suppl. 195:18-24. Ishimaru, H., Ishikawa, K., Ohe, Y., Takahashi, A., Maruyama, Y. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res., 1996; 709:155-162. Jagust, W.J., Eberling, J.L., Reed, B.R., Mathis, C.A., Budinger, T.F. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:254-262. Jendroska, K. et al. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol., 1995; 90:461-466. Joutel, A. et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopaphy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann. New York Acad. Sci., 1997; 826:213-217. Kalaria, R.N. Cerebrovascular degeneration is related to amyloid-b protein deposition in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:263-271. Kish, S.J. Brain energy metabolizing enzymes in Alzheimer's disease: a-Ketoglutarate dehydrogenase complex and cytochrome oxidase. Ann. New York Acad. Sci., 1997; 826:218-228. Kisilevsky, R. Can deposition of amyloid be prevented in Alzheimer's disease? Ann. New York Acad. Sci., 1997; 826:117-127. Launer, L.J. et al. The association between midlife blood pressure levels and late-life cognitive function. 15-year longitudinal study of blood pressure and dementia. Lancet 1995; 347:1141-1145. Maneiro, E., Lombardi, V.R.M., Lagares, R., Cacabelos, R. An experimental model to study the cytotoxic effects induced by b-amiloid, histamine, LPS ans serum from Alzheimer patients on cultured rat endothelial cells. Meth. Find. Exp. Clin. Pharmacol., 1997; 19:5-12. Mayer, P.L., Kier, E.L. The controversy of the periventricular white matter circulation: A review of the anatomic literature. Am. J. Neuroradiol., 1991; 12:223-228. Meier-Ruge, W.A., Bertoni-Freddari, C. The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev. Neurosci., 1996; 7:1-9. Meier-Ruge, W.A., Bertoni-Freddari, C. Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type. Ann. New York Acad. Sci., 1997; 826:229-241. Meier-Ruge, W.A., Bertoni-Freddari, C., Iwanoff, P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 1994; 40:246-252. Miyakawa, T. Electron microscopy of amyloid fibrils and microvessels. Ann. New York Acad. Sci., 1997; 826:25-34. Moody, D.M., Bell, M.A., Challa, V.R. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study. Am. J. Neuroradiol., 1990; 11:431-439. Moody, D.M., Brown, W.R., Challa, V.R., Ghazi-Birry, H.S., Reboussin, D.M. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:103-116. Moody, D.M. et al. Brain microemboli during cardiac surgery or aortography. Ann. Neurol., 1990; 28:477-486. Moroney, J.T., Bagiella, E., Desmond, D.W., Paik, M.C., Stern, Y., Tatemichi, T.K. Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann. New York Acad. Sci., 1997; 826:433-436. Munoz, D.G., Erkinjunti, T., Gaytan-García, S., Hachinski, V. Serum protein leakage in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:173-189. Nagata, K. et al. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:272-281. Nair, P.K., Hellums, J., Olson, J. Prediction of oxygen transport rates in blood flowing in large capillaries. Microvasc. Res., 1989; 36:269-285. Nelson, M.D., Gonzales-Gomez, I., Gilles, F.H. The search for human telencephalic ventriculofugal arteries. Am. J. Neuroradiol., 1991; 12:215-222. Olichney, J.M., Ellis, R.J., Katzman, R., Sabbagh, M.N., Hansen, L. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:493-497. Pantoni, L., Garcia, J.H. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann. New York Acad. Sci., 1997; 826:92-102. Parker, W.D., Davis, R.E. Mitochondrial DNA defects as a causative event in Alzheimer's disease. En: Neurodegenerative Disease: Mitochondria and free radicals in pathogenesis. M.F. Beal, N. Howell, I. Bodis-Wollner, Eds. Wiley, New York, 1997. Plump, A.S., Breslow, J.L. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu. Rev. Nutrition 1995; 15:495-518. Premkumar, D.L. et al. Apolipoprotein E e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology in Alzheimer's disease. Am. J. Pathol., 1996; 148:2083-2095. Prince, M., Cullen, M., Mann, A. Risk factor for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 1994; 44:97-104. Ravens, J.R. Anastomoses in the vasculaar bed of the human cerebrum. En: Pathology of cerebral microcirculation. J. Cervós-Navarro, Eds., Walter de Gruyter, Berlin, 1974;26-38. Roberts, G.W. et al. Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiat., 1994; 57:419-425. Roder, H.M., Eden, P.A., Ingram, V.M. Brain protein kinase Pk40 converts tau into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Commun., 1993; 193:639-647. Romanul, F.C., Abramowicz, A. Changes in brain and pial vessels in arterial border zone. Arch. Neurol., 1964; 11:40-65. Roses, A.D., Saunders, A.M. ApoE, Alzheimer's disease, and recovery from brain stress. Ann. New York Acad. Sci., 1997; 826:200-212. Rowbotham, G.F., Little, E. Circulation of the cerebral hemispheres. Br. J. Surg., 1965; 52:8-21. Schieve, J.F., Wilson, W.P. The influence of age, anesthesia, and cerebral arteriosclerosis on cerebral vascular reactivity to CO2. Am. J. Med., 1953; 15:171-174. Sheu, K.F.R. A gene locus of dihydrolipoyl succinyltransferase (DLST) associated with Alzheimer's disease. J. Neurochem., 1996; 66(Suppl. 1):S10. Skoog, I., Nilson, L., Palmertz, B., Andreasson, L., Svanborg, A. A population-based study of dementiaa in 85-year-olds. New Engl. J. Med., 1993; 328:153-158. Small, G.W. et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995; 273:942-947. Sparks, D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:128-146. Sparks, D.L. et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 1990; 11:601-607. Spielmeyer, W. Zur Pahogenese ortlich elektiver Gehirnver-anderungen. Z. Ges. Neurol. Psychiat., 1925; 99:756-776. Strittmatter, W.J. et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 1994; 91:11183-11186. Thomas, T., Thomas, G., McLendon, C., Sutton, T., Mullan, M. b-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380:168-171. Tomimoto, H., Wakita, H., Akiguchi, J., Nakamura, S., Kimura, J. Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress. J. Cereb. Blood Flow Metab., 1994; 14:565-573. Tournier-Lasserve, E. et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) maps on chromosome 19q12. Nat. Genet., 1993; 3:256-259. Vander Eeecken, H.M., Adams, R.D. The anatomy and functional significance of the meningeal arterial anastomoses of the human brain. J. Neuropathol. Exp. Neurol., 1953; 12:132-157. Vinters, H.V. Cerebral amyloid angiopathy: A critical review. Stroke 1987; 18:311-324. Wilson, P.W.F. et al. Apolipoprotein E alleles, dyslipidemia and coronary heart disease. JAMA 1994; 272:1666-1671. Wisniewski, H.M., Vorbrodt, A.W., Wegiel, J. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:161-172. Xu, P.T. et al. Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: Human-like patterns of immunoreactivity in centrl nervous system not observed in wild type mice. Neurobiol. Dis., 1996; 3:229-245. Yamaguchi, F., Meyer, J.S., Yamamoto, M., Sakai, F., Shaw, T. Noninvasive regional cerebral blood flow measurements in dementia. Arch. Neurol., 1980; 37:410-418. Zarow, C., Barron, E., Chang, H., Perlmutter, L.S. Vascular basement membrane pathology and Alzheimer's disease. Ann. New York Acad. Sci., 1997; 826:147-160. Zhang, S.H., Reddick, R.L., Piedrahita, J.A., Maeda, N. Spontaneous hypercholesterolemiaa and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258:468-471. Zlokovic, B.V., Begley, D.J., Djuricic, B.M., Mitrovic, D.M. Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain. Method and application to N-methyl-a-aminoisobutyric acid. J. Neurochem., 1986; 46:1444-1451.
Introducción
|
||||||||||||||||||||
|
|
|
a |
||||||||||||||||||||
|
|
|
Proyecto web: Cograf |
